Welcome to the DZIF -

the German Center for Infection Research

Research Areas

DZIF is doing research in nine areas:

Community-Acquired Infections at Mucosal Interfaces

Hepatitis

HIV

Infections of the Immunocompromised Host

Healthcare-Associated Infections

Malaria and Neglected Tropical Diseases

Emerging Infections

Novel Antibiotics

Tuberculosis

News

News and Press Releases:

Two containers of antiretroviral combination drugs labeled “Darunavir/Cobicistat/Emtricitabine/Tenofoviralafenamide” and “Bictegravir/Emtricitabine/Tenofoviralafenamide” stand on a countertop in a bright hospital corridor.
© MHH/Karin Kaiser

MHH study investigates treatment safety in cases of late HIV diagnosis

Two gloved hands hold a needle with an ampoule containing a clear liquid. The needle is inserted into the upper arm of a patient.
© Mufid Majnun on Unsplash

Flu vaccination remains essential—also in light of international case numbers

Reports are currently reaching us from Japan and several countries in Southeast Asia about an increased number of severe cases of illness caused by the influenza A/H3N2 virus. Experts at the German
The newly elected DZIF Excecutive Board (from left): Prof. Dirk Busch, Prof. Susanne Herold, Prof. Marylyn Addo, Prof. Thomas Pietschmann, and Prof. Andreas Peschel
© DZIF

Continuity and a breath of fresh air: New DZIF Executive Board elected

Five outstanding researchers were elected to the Executive Board at the general meeting of the German Center for Infection Research (DZIF). Prof. Dirk Busch, Prof. Andreas Peschel, and Prof. Thomas
Graphical representation of the crystal structures of LecA and tolcapone
© HIPS/Leusmann

Parkinson's drug as basis for new anti-infectives

When the bacterial pathogen Pseudomonas aeruginosa infects the body, it uses the sugar-binding protein LecA to attach itself to human cells, invade them, and form so-called biofilms. LecA thus plays a
eFIT Lab
© KyooBe Tech GmbH

Collaboration between KyooBe Tech and the German Center for Infection Research

The technology company KyooBe Tech GmbH and the German Center for Infection Research (DZIF) have signed a memorandum of understanding to collaborate on future research and development projects. The
All news

What is the DZIF? Find out more in our

DZIF movie

More than 700 people work at the DZIF with the common goal of translating basic research into clinical practice. The well-being of the patient is our primary focus. Get more insights in our new DZIF film:

Watch the movie
A GIF animation with clips from the DZIF film.

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists
CAPTCHA
4 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Follow us on:

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Find Media Content

Research in Focus

Hamburg - Lübeck - Borstel - Riems

Clinical Tuberculosis Center

The Clinical Tuberculosis Center provides the expertise and infrastructure for the optimization, prevention, diagnosis, and treatment of tuberculosis (TB) as well as for translating research results into clinical practice. The main objectives of the Clinical Tuberculosis Center include coordinating clinical research activities involving the DZIF TB cohort. This cohort includes [...]

Read more
Hannover - Braunschweig | Heidelberg | München | Tübingen

Transplant Cohort

Medical data and biological samples obtained from transplant patients are collected and managed across Germany with the help of the DZIF Transplant Cohort. The data and samples form the basis of scientific studies which investigate the connections between numerous factors influencing an organ’s susceptibility to infection and organ function. In [...]

Read more
Hannover - Braunschweig

Preclinical development of Amidochelocardins

The challenge of antibiotic drug development today is the discovery and optimisation of novel bioactive compounds that do not show cross-resistances with clinically applied antibiotics, ideally due to a novel mode of action (MoA) which adresses unexploited microbial targets. In the case of chelocardin, this antibiotic substance was identified several [...]

Read more
Tübingen

New strategies for specific eradication of Staphylococcus aureus

In this project, the scientists develop genetically engineered phage lysins and specific bacteriocins for the elimination of hospital germs such as Staphylococcus aureus, they clarify mechanisms of potential resistance mechanisms, and they analyse whether broad-spectrum or specifically acting agents have a more effective and lasting effect on colonization by [...]

Read more

Our Partner Sites

Location

Hannover - Braunschweig

Research areas
Contact person
Silke Hartmann

Dr. Silke Hartmann

Hannover Medical School
Partner Site Manager Hannover - Braunschweig
Project Manager Community-Acquired Infections at Mucosal Interfaces
E-Mail Send mail
More about this location
Location

Heidelberg

Research areas
Contact person
Stephan Urban

Prof. Dr. Stephan Urban

Heidelberg University
Deputy Coordinator Hepatitis
DZIF Professor "Translational Virology"
Partner Site Speaker Heidelberg
E-Mail Send mail
More about this location
Location

Hamburg - Lübeck - Borstel - Riems

Research areas
Contact person
More about this location
Location

Bonn - Köln

Research areas
Contact person
Prof Achim Hörauf: Coordinator of the consortium "Neglected tropical diseases" at DZIF.

Prof. Dr. Achim Hörauf

University Hospital Bonn
Deputy Partner Site Speaker Bonn-Köln
Deputy Coordinator Malaria and Neglected Tropical Diseases
E-Mail Send mail
More about this location
München Tübingen Heidelberg Giessen – Marburg – Langen Bonn – Köln Hannover – Braunschweig Hamburg – Lübeck Borstel – Riems